Fabio A. Vigil, Ph.D.

Novel therapy administered after TBI prevents brain damage

July 12, 2019

An experimental treatment given to mice after a traumatic brain injury (TBI) reduced damage almost to the levels of mice that never had a TBI, researchers at UT Health San Antonio reported. The study was published July 4  in the Journal of Cerebral Blood Flow and Metabolism. The scientists hope to convert the discovery into […]

Read more

Andrea Marks

Marks promoted to senior executive VP and chief operating officer

July 11, 2019

Andrea M. Marks, M.B.A., CPA, has been promoted to senior executive vice president (EVP) and chief operating officer (COO) of UT Health San Antonio.  Marks currently serves as vice president and chief financial officer and will assume the role of senior EVP and COO on Oct. 1 of this year upon the retirement of Michael […]

Read more

Jennifer Donegan, Ph.D.

Novel gene therapy reduces schizophrenia symptoms

July 8, 2019

Human research has shown that the hippocampus is hyperactive in schizophrenia, Dr. Donegan said. It is like a car engine that idles too high in park.

Read more

Jennifer Donegan, Ph.D.

Novel gene therapy curbs schizophrenia symptoms

July 5, 2019

Highlight:  An experimental treatment tested at UT Health San Antonio reduced delusions and hallucinations while improving cognitive skills in rats. Jennifer Donegan, Ph.D., and colleagues at UT Health San Antonio describe a novel, experimental approach to treating schizophrenia in the journal Nature Communications (published June 27). If developed into a human therapy, the new strategy […]

Read more

E-scooter accidents causing facial injuries

June 28, 2019

                More people are out and about in the summer, and many are riding on electric scooters downtown. Scott Farber, M.D., plastic and reconstructive surgeon at UT Health San Antonio, says his team is treating an increased number of people who fell off the scooters, particularly for facial […]

Read more

Study finds CTE in 6% of subjects

June 21, 2019

Nearly 6% of athletes and non-athletes were found to have the neurodegenerative disorder chronic traumatic encephalopathy (CTE) in the largest, and broadest, study conducted of the disease to date. The findings were published June 14 in the international journal Brain Pathology. “Generally our findings point to CTE being more common in athletes and more common in […]

Read more